Aim Several latest reports have revealed that dipeptidyl peptidase (DPP)-4 inhibitors have suppressive effects about atherosclerosis in apolipoprotein E-null (diabetic mice were administered the DPP-4 inhibitor vildagliptin in normal water and co-infused with either saline, the GLP-1 receptor blocker, exendin(9C39),…